ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1191

The Kimriss Bone Marrow Lesion Score in Patients with Osteoarthritis of the Knee Correlates with WOMAC Pain Status Using Target-Lesion Based Scoring Methodology; Data from the Osteoarthritis Initiative

David McDougall1, Jacob Jaremko1, RG Lambert1 and Walter P. Maksymowych2, 1Radiology, University of Alberta, Edmonton, AB, Canada, 2Medicine/Rheumatic Dis Unit, University of Alberta, Edmonton, AB, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Knee, MRI, Validity and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging (MRI)

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Inflammatory components of osteoarthritis including bone marrow lesions (BML) may be a target for therapy.  Limited literature quantifies the relation of these markers on MRI with respect to pain and dysfunction in hip osteoarthritis.  We sought to correlate the extent of BML using a validated scoring methodology, the Knee Inflammation MRI Scoring System (KIMRISS), with a validated pain score, WOMAC, in patients with hip osteoarthritis.  In KIMRISS a score of 0 (no BML) or 1 (BML present) is assigned to each region of bone in each slice using a customized grid overlay with regions each approximately 1 cm x 1 cm in size; a higher KIMRISS BML sum score directly represents a larger volume of BML.

Methods

Data for these analyses are from the OAI public use data set(s). MRI scans at enrolment and 1 year follow-up were evaluated in 80 patients for BML score by two readers using KIMRISS methodology. The WOMAC pain score was available for each patient at the same time points.  We assessed association of BML status and change scores with WOMAC pain status and change scores using correlation (Pearson chi square) and by multivariate regression adjusted for age, sex, Kellgren-Lawrence grade, and baseline scores for WOMAC pain.

Results

The volume of BML correlated highly with both WOMAC pain score (chi-square 0.86 p <0.0001) and change in WOMAC pain score between enrolment and 1 year (chi-square 0.84 p<0.0001)

Conclusion

KIMRISS BML score correlates highly with pain in patients with hip osteoarthritis, and was highly responsive to change.  KIMRISS offers an alternative approach for scoring bone marrow lesions in knee osteoarthritis that is designed to be easily learned and can potentially be automated in future.


Disclosure:

D. McDougall,
None;

J. Jaremko,
None;

R. Lambert,
None;

W. P. Maksymowych,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-kimriss-bone-marrow-lesion-score-in-patients-with-osteoarthritis-of-the-knee-correlates-with-womac-pain-status-using-target-lesion-based-scoring-methodology-data-from-the-osteoarthritis-initiativ/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology